Affini-T Therapeutics’ Post

Great course that delves into the nuances of oncology #clinicaltrials, unraveling the unique challenges and differences that set #oncologytrials apart from other clinical trials. Course outline and what you'll learn:  https://bit.ly/3ttTINZ #clinicaltrials #clinicalresearch #clinicalstudies #clinicalresearchtraining #oncologytrials

In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology

I am delighted to share Oncology and Therapy's updated 2023 metrics. Many thanks to our readers, authors, board members and editorial staff for their fantastic contributions year-on-year. https://lnkd.in/d_sVXS9d #oncology #medicine

In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Jakki James and Kristina Reeder review the frustratingly limited patient access in precision oncology, the root causes, and five best practices that can bridge the gap. Learn how oncology experts are empowering patients, sites, and physicians to participate in and accelerate precision oncology. Read the full article below and subscribe to stay up to date on the latest #NovelInsights from our clinical trial newsletter! #PatientsFirst #WithHeart #PrecisionOncology #Oncology

🧡Hosted by #SyneosHealth and the Society for Clinical Research Sites (SCRS), our latest on-demand webinar explores the complexities and paths towards enhanced diversity in oncology trials at the site level.   Watch the full webinar here: https://lnkd.in/dXBXVQFd #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers #ClinicalSolutions #DiversityinOncologyTrials

Today, we announced a poster presentation at the American Society of Clinical Oncology (ASCO)) annual meeting highlighting interim results from the ongoing Phase 1 ELiPSE-1 study of CNTY-101 in relapsed or refractory (R/R) #lymphoma. The poster showcases CNTY-101’s continued encouraging preliminary efficacy and manageable safety profile for with no observed DLTs or GvHD. Learn more: https://bit.ly/3RaEI3k #ASCO2024

Which #cancers are HCPs talking about online at American Society of Clinical Oncology (ASCO) ? Presentations on studies such as the #CROWN and #PALOMA-3 trials are causing the #lungcancer conversation to dominate. Watch this space for more updates from the next three days of #ASCO24! #WhatHCPsThink

Early intervention of palliative care for patients with cancer-related symptoms is extremely important. This insightful article from ABC News America, featuring advice from the American Society of Clinical Oncology (ASCO), highlights the importance of early referral to palliative care on a global scale. Read the article here ➡️ https://ow.ly/eoEH50SmVB6

New from Michigan Oncology Quality Consortium (MOQC) learn about the development of a virtual interdisciplinary communication Workshop designed to strengthen communication across ambulatory oncology team members. #CQISundayRead #QualityImprovement https://ow.ly/gm3750Q51nG

Check out the latest Oncology Insights article from Simone Ndujiuba, PharmD, BCOP as she discusses the key findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting. Learn more here: https://bit.ly/3SePnKM